IFNG and COVID-19: For the donor who showed an immunologically significant response to most of the tested synthetic epitope candidates (for 6 out of 8) in PBMCs collected within 7 weeks of a resolved COVID-19, we also tested the IFN-γ release by PBMCs collected before COVID-19 diagnosis and 23 weeks after it.